BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12364635)

  • 1. Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset.
    Komura K; Sato S; Fujimoto M; Hasegawa M; Takehara K
    Rheumatology (Oxford); 2002 Oct; 41(10):1149-54. PubMed ID: 12364635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum soluble CD44 level in sarcoidosis.
    Kasuga I; Minemura K; Nasu H; Hibi N; Tago H; Nagate A; Kunisawa A; Ohyashiki JH; Ohyashiki K
    Int J Mol Med; 2000 Dec; 6(6):679-82. PubMed ID: 11078828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
    J Rheumatol; 2011 Oct; 38(10):2193-7. PubMed ID: 21807780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
    Clin Rheumatol; 2011 Jun; 30(6):825-30. PubMed ID: 21246230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating CD40L concentrations in patients with systemic sclerosis.
    Komura K; Sato S; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2004 Mar; 31(3):514-9. PubMed ID: 14994397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
    J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.
    Kikuchi K; Ihn H; Sato S; Igarashi A; Soma Y; Ishibashi Y; Takehara K
    Arch Dermatol Res; 1994; 286(2):77-80. PubMed ID: 8154928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
    Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
    Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.
    Sato S; Nagaoka T; Hasegawa M; Nishijima C; Takehara K
    Dermatology; 2000; 200(3):196-201. PubMed ID: 10828626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
    Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2012 Sep; 22(5):668-75. PubMed ID: 22160844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
    Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
    Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.